CORC

浏览/检索结果: 共46条,第1-10条 帮助

限定条件                    
已选(0)清除 条数/页:   排序方式:
Long-Term Inter-Protocol KV CBCT Image Quality Assessment On the Halcyon Linac Via An Automated QA Approach with the QUART Phantom 会议论文
作者:  Peng, J.;  Li, H.;  Laugeman, E.;  Mazur, T.;  Lam, D.
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
Multi-omics profiling reveals metabolic heterogeneity of triple-negative breast cancer 会议论文
作者:  Shao, Z. -M.;  Gong, Y.;  Ji, P.;  Yu, T. -J.;  Hu, X.
收藏  |  浏览/下载:16/0  |  提交时间:2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Clinical Characterization of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Hu, Y.;  Liu, Z.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载:33/0  |  提交时间:2019/12/05
Atezolizumab monotherapy in Chinese patients with locally advanced or metastatic solid tumours 会议论文
作者:  Shen, L.;  Zhang, L.;  Hu, X.;  Pan, H.;  Liu, T.
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Clinical Characterization Of ERBB2 Exon 20 Insertions and Heterogeneity of Outcomes to Afatinib in Chinese Lung Cancers 会议论文
作者:  Liu, Z.;  Hu, Y.;  Wu, L.;  Cao, J.;  Yang, Z.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Phase III trial of chidamide, a subtype-selective histone deacetylase (HDAC) inhibitor, in combination with exemestane in patients with hormone receptor-positive advanced breast cancer 会议论文
作者:  Jiang, Z.;  Li, W.;  Hu, X.;  Zhang, Q.;  Sun, T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05
Racial/ethnic differences in prostate cancer genomic alterations 会议论文
作者:  Dobi, Albert;  Petrovics, Gyorgy;  Tan, Shyh-Han;  Li, Hua;  Young, Denise
收藏  |  浏览/下载:9/0  |  提交时间:2019/12/05
A Randomized Phase 3 Trial of Capecitabine With or Without Irinotecan Driven By UGT1A1 in Neoadjuvant Chemoradiation of Locally Advanced Rectal Cancer (CinClare): Results of Interim Analysis 会议论文
作者:  Zhu, J.;  Zhang, Z.;  Sun, X.;  Wang, X.;  Zhang, T.
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/05
A phase III trial of muparfostat (PI-88) as adjuvant therapy in patients with hepatitis virus related hepatocellular carcinoma (HV-HCC) after resection 会议论文
作者:  Chen, P-J.;  Lee, P-H.;  Han, K-H.;  Fan, J.;  Cheung, T. T.
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/05


©版权所有 ©2017 CSpace - Powered by CSpace